EMEA-000637-PIP02-10-M06
Key facts
Invented name |
Fosrenol and associated names
|
Active substance |
Lanthanum carbonate hydrate
|
Therapeutic area |
Uro-nephrology
|
Decision number |
P/0303/2018
|
PIP number |
EMEA-000637-PIP02-10-M06
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of hyperphosphataemia
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Takeda Pharmaceuticals International AG Ireland Branch
E-mail: medinfoemea@takeda.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|